Transporters, enzymes, and enalapril removal in a rat (CC531-induced) liver metastatic model

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 293, Issue 5, 2007, Pages

  Liu, Lichuan ^a   Sun, Huadong ^a   Valji, Wiqas Y ^a   Pang, K Sandy ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Kinetics; Microcirculation

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALBUMIN; BILE SALT; CARBOXYLESTERASE; CARRIER PROTEIN; CYTOCHROME P450; ENALAPRIL; ENALAPRILAT; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN P; INDICATOR; LIVER ENZYME; MULTIDRUG RESISTANCE PROTEIN 2;

ALBUMIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VOLUME; CANCER CELL CULTURE; CARCINOGENESIS; COLON ADENOCARCINOMA; CONTROLLED STUDY; DISEASE MODEL; DRUG EXCRETION; DRUG METABOLISM; HEPATIC VEIN; LIVER METASTASIS; LIVER PERFUSION; LIVER SINUSOID; MALE; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE; STEADY STATE; WESTERN BLOTTING; WISTAR ALBINO GLAXO RAT;

ANIMALS; ENALAPRIL; ENZYMES; LIVER NEOPLASMS; MALE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; RATS; RATS, INBRED STRAINS;

EID: 36148997607     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00350.2006     Document Type: Article

References (50)

1. Abdel-Razzak Z, Loyer P, Fautrel A, Gautier JC, Corcos L, Turlin B, Beaune P, Guillouzo A. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 44: 707-715, 1993.
2. Abu-Zahra TN, Pang KS. Effect of zonal transport and metabolism on hepatic removal: enalapril hydrolysis in zonal, isolated rat hepatocytes in vitro and correlation with perfusion data. Drug Metab Dispos 28: 807-813, 2000.
3. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 357: 539-545, 2001.
4. Baxter LT, Zhu H, Mackensen DG, Jain RK. Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice. Cancer Res 54: 1517-1528, 1994.
5. Bonin S, Pascolo L, Croce LS, Stanta G, Tiribelli C. Gene expression of ABC proteins in hepatocellular carcinoma, perineoplastic tissue, and liver diseases. Mol Med 8: 318-325, 2002.
6. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 30: 969-977, 1954.
7. Burgener FA. Peripheral hepatic artery embolization in rabbits with VX2 carcinomas of the liver. Cancer 46: 56-63, 1980.
8. de Lannoy IA, Nespeca R, Pang KS. Renal handling of enalapril and enalaprilat: studies in the isolated red blood cell-perfused rat kidney. J Pharmacol Exp Ther 251: 1211-1222, 1989.
9. Dimanche-Boitrel MT, Vakaet L Jr, Pujuguet P, Chauffert B, Martin MS, Hammann A, Van Roy F, Mareel M, Martin F. In vivo and in vitro invasiveness of a rat colon-cancer cell line maintaining E-cadherin expression: an enhancing role of tumor-associated myofibroblasts. Int J Cancer 56: 512-521, 1994.
10. Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 4: 11-22, 2004.
11. Fu XY, Besterman JM, Monosov A, Hoffman RM. Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. Proc Natl Acad Sci USA 88: 9345-9349, 1991.
12. Gheuens E, van der Heyden S, Elst H, Eggermont A, Van Oosterom A, De Bruijn E. Multidrug resistance in rat colon carcinoma cell lines CC531, CC531mdr+ and CC531rev. Jpn J Cancer Res 84: 1201-1208, 1993.
13. Gonda T, Ishida H, Yoshinaga K, Sugihara K. Microvasculature of small liver metastases in rats. J Surg Res 94: 43-48, 2000.
14. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2: 48-58, 2002.
15. Hagenaars M, Ensink NG, Basse PH, Hokland M, Nannmark U, Eggermont AM, van de Velde CJ, Fleuren GJ, Kuppen PJ. The microscopic anatomy of experimental rat CC531 colon tumour metastases: consequences for immunotherapy? Clin Exp Metastasis 18: 189-196, 2000.
16. Hagenaars M, Koelemij R, Ensink NG, van Eendenburg JD, van Vlierberghe RL, Eggermont AM, van de Velde CJ, Fleuren GJ, Kuppen PJ. The development of novel mouse monoclonal antibodies against the CC531 rat colon adenocarcinoma. Clin Exp Metastasis 18: 281-289, 2000.
17. Hara Y, Ogata Y, Shirouzu K. Early tumor growth in metastatic organs influenced by the microenvironment is an important factor which provides organ specificity of colon cancer metastasis. J Exp Clin Cancer Res 19: 497-504, 2000.
18. Heijstek MW, Kranenburg O, Borel Rinkes IH. Mouse models of colorectal cancer and liver metastases. Dig Surg 22: 16-25, 2005.
19. Heuff G, Oldenburg HS, Boutkan H, Visser JJ, Beelen RH, Van Rooijen N, Dijkstra CD, Meyer S. Enhanced tumour growth in the rat liver after selective elimination of Kupffer cells. Cancer Immunol Immunother 37: 125-130, 1993.
20. Huang LR, Coughtrie MW, Hsu HC. Down-regulation of dehydroepiandrosterone sulfotransferase gene in human hepatocellular carcinoma. Mol Cell Endocrinol 231: 87-94, 2005.
21. Inoue Y, Kashima Y, Aizawa K, Hatakeyama K. A new rat colon cancer cell line metastasizes spontaneously: biologic characteristics and chemotherapeutic response. Jpn J Cancer Res 82: 90-97, 1991.
22. Jain RK. Barriers to drug delivery in solid tumors. Sci Am 271: 58-65, 1994.
23. Jain RK, Munn LL, Fukumura D. Dissecting tumour pathophysiology using intravital microscopy. Nat Rev Cancer 2: 266-276, 2002.
24. Kollmar O, Schilling MK, Menger MD. Experimental liver metastasis: standards for local cell implantation to study isolated tumor growth in mice. Clin Exp Metastasis 21: 453-460, 2004.
25. Liu L, Cui Y, Chung AY, Shitara Y, Sugiyama Y, Keppler D, Pang KS. Vectorial transport of enalapril by Oatp1a1/Mrp2 and OATP1B1 and OATP1B3/MRP2 in rat and human livers. J Pharmacol Exp Ther 318: 395-402, 2006.
26. Liu LX, Zhang WH, Jiang HC. Current treatment for liver metastases from colorectal cancer. World J Gastroenterol 9: 193-200, 2003.
27. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
28. MacLeod SL, Nowell S, Massengill J, Jazieh A, McClure G, Plaxco J, Kadlubar FF, Lan NP. Cancer therapy and polymorphisms of cytochromes P450. Clin Chem Lab Med 38: 883-887, 2000.
29. Marquet RL, Westbroek DL, Jeekel J. Interferon treatment of a transplantable rat colon adenocarcinoma: importance of tumor site. Int J Cancer 33: 689-692, 1984.
30. Michael M, Doherty MM. Tumoral drug metabolism: overview and its implications for cancer therapy. J Clin Oncol 23: 205-229, 2005.
31. Moskaluk CA, Duray PH, Cowan KH, Linehan M, Merino MJ. Immunohistochemical expression of pi-class glutathione S-transferase is down-regulated in adenocarcinoma of the prostate. Cancer 79: 1595-1599, 1997.
32. Nies AT, Konig J, Pfannschmidt M, Klar E, Hofmann WJ, Keppler D. Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma. Int J Cancer 94: 492-499, 2001.
33. Pang KS, Rowland M. Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model Influence of hepatic blood flow, plasma and blood cells binding, and the hepatocellular enzymatic activity on hepatic drug clearance. J Pharmacokinet Biopharm 5: 625-653, 1977.
34. 2O as a reference indicator in liver multiple indicator dilution studies. Am J Physiol Gastrointest Liver Physiol 261: G929-G936, 1991.
35. Pang KS, Sherman IA, Schwab AJ, Geng W, Barker F 3rd, Dlugosz JA, Cuerrier G, Goresky CA. Role of the hepatic artery in the metabolism of phenacetin and acetaminophen: intravital microscopic and multiple-indicator dilution study in perfused rat liver. Hepatology 20: 672-683, 1994.
36. Pang KS, Wang PJ, Chung AY, Wolkoff AW. The modified dipeptide, enalapril, an angiotensin-converting enzyme inhibitor, is transported by the rat liver organic anion transport protein. Hepatology 28: 1341-1346, 1998.
37. Rodenbach M, Eyol E, Seelig MH, Berger MR. Combination treatment of CC531-lac-Z rat liver metastases by chemoembolization with pemetrexed disodium and gemcitabine. J Cancer Res Clin Oncol 131: 289-299, 2005.
38. Sadahiro S, Suzuki T, Ishikawa K, Tanaka Y, Masuda T, Nakamura T, Yasuda S, Makuuchi H, Murayama C. Pharmacokinetics of 5-fluorouracil following hepatic intra-arterial infusion in a VX2 hepatic metastasis model. Jpn J Clin Oncol 33: 377-381, 2003.
39. Scheringa M, Keizer A, Jeekel J, Marquet RL. Anti-tumor effect of recombinant murine TNF-alpha (rMuTNFa) given by continuous i.v. infusion as compared with repeated i.v. injections in a rat liver metastasis model. Int J Cancer 43: 905-909, 1989.
40. Schuetz EG, Furuya KN, Schuetz JD. Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. J Pharmacol Exp Ther 275: 1011-1018, 1995.
41. Sekine I, Saijo N. Polymorphisms of metabolizing enzymes and transporter proteins involved in the clearance of anticancer agents. Ann Oncol 12: 1515-1525, 2001.
42. Sparreboom A, Danesi R, Ando Y, Chan J, Figg WD. Pharmacogenomics of ABC transporters and its role in cancer chemotherapy. Drug Resist Updat 6: 71-84, 2003.
43. Sun H, Liu L, Pang KS. Increased estrogen sulfation of estradiol 17β-D-glucuronide in the metastatic tumor rat liver. J Pharmacol Exp Ther 319: 818-831, 2006.
44. Thomas C, Nijenhuis AM, Timens W, Kuppen PJ, Daemen T, Scherphof GL. Liver metastasis model of colon cancer in the rat: immunohistochemical characterization. Invasion Metastasis 13: 102-112, 1993.
45. Townsend DM, Tew KD. The role of glutathione-S-transferase in anticancer drug resistance. Oncogene 22: 7369-7375, 2003.
46. Varin F, Huet PM. Hepatic microcirculation in the perfused cirrhotic rat liver. J Clin Invest 76: 1904-1912, 1985.
47. Wang J, Yang M, Hoffman RM. Visualizing portal vein metastatic trafficking to the liver with green fluorescent protein-expressing tumor cells. Anticancer Res 24: 3699-3702, 2004.
48. Wilson J, Balkwill F. The role of cytokines in the epithelial cancer microenvironment. Semin Cancer Biol 12: 113-120, 2002.
49. Wittmer A, Khazaie K, Berger MR. Quantitative detection of lac-Z-transfected CC531 colon carcinoma cells in an orthotopic rat liver metastasis model. Clin Exp Metastasis 17: 369-376, 1999.
50. Yeatman TJ, Bland KI, Copeland EM 3rd, Kimura AK. Tumor cell-surface galactose correlates with the degree of colorectal liver metastasis. J Surg Res 46: 567-571, 1989.